A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

Clinical trial NCT04814615 · UNKNOWN

Trial details

NCT number: NCT04814615
Sponsor: Hoag Memorial Hospital Presbyterian
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2021-03-08
Primary completion: 2026-01-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.